Stanford Researchers Develop Methods for Analyzing Off-label Drug Use

March 2014
News India Times;3/7/2014, Vol. 45 Issue 10, p10
The article reports on the development of a group of researchers at Stanford University School of Medicine, led by Nigam Shah, of methods to extract and sort information about off-label drug uses from electronic medical records.


Related Articles

  • In This Issue.  // Clinical Pharmacology & Therapeutics;May2012, Vol. 91 Issue 5, p753 

    An introduction is presented in which the editor discusses various reports within the issue on topics including safety related to off-label use of drugs, electronic health record for product labeling and sildenafil increasing skin blood flow in patients with primary Raynaud's phenomenon.

  • More than 10% of prescriptions in one Canadian province were for drugs not approved to treat the patient's condition, a new study finds.  // MondayMorning;4/23/2012, Vol. 20 Issue 17, p1 

    The article presents information on prescriptions by the doctors for drugs that are being used off label for patient's health. It mentions that Tewodros Eguale from McGill University in Montreal and colleagues studied data from electronic health records. It was observed that four out of five...

  • Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study. de Souza Jr, Alcidésio Sales; dos Santos, Djanilson Barbosa; Rey, Luís Carlos; Medeiros, Marina Garruti; Vieira, Marta Gonçalves; Coelho, Helena Lutéscia Luna; de Souza, Alcidésio Sales Jr // BMC Pediatrics;1/21/2016, Vol. 16, p1 

    Background: Neonates admitted to neonatal intensive care units (NICU) are exposed to a wide variety of drugs, most without any data on safety and efficacy.Objective: To describe the drugs prescribed to different groups of neonates hospitalized in a NICU, and to analyze...

  • Editor's Desk. Off-Label. Cox, John V. // Journal of Oncology Practice;Mar2011, Vol. 7 Issue 2, p69 

    An introduction to the journal is presented in which the editor discusses various reports published within the issue including one by Erin E. Hahn on survivorship care plan (SCP), one by Eliezer M. van Allen and colleagues on the off-label use of Rituximab, and one by William L. Owens and...

  • GREAT MEDICAL MINES. Devitt, Elizabeth // Stanford Medicine;Spring2014, Vol. 31 Issue 1, p38 

    The article focuses on data mining of electronic health records (EHRs) and other health-related databases, and its positive implications for clinicians and patient care. Topics include Stanford University professor Nigam Shah's efforts to search EHRs for risk factors of uveitis in young...

  • Speak Out. Wright, David; Avallone, Anthony N.; Berger, Aaron; Wrenn, John // Urology Times;4/1/2009, Vol. 37 Issue 4, p30 

    The article presents answers to a question on whether pharmaceutical companies be allowed to market pharmaceutical products for off-label use.

  • Off-Label Drug Uses. . Generali, Joyce A.; Cada, Dennis J. // Hospital Pharmacy;Mar2010, Vol. 45 Issue 3, p208 

    This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This...

  • SLEEPING PILLS. Hanau, Michael S. // Primary Psychiatry;May2008, Vol. 15 Issue 5, p23 

    A letter to the editor is presented in response to an article by Milton K. Erman which critiques the popularity of trazodone and other non-benzodiazepine analogs for off-label use.

  • Perspective on 'Off-Label'.  // Review of Optometry;5/15/2012 Clinical Guide to Ophtha, p22A 

    The article offers perspectives on the off-label use of approved medications which is considered as a legal and necessary part in the practice of medicine for optimal patient care.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics